MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Free Forum Hosting
 

Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
Friends With RSD/Chronic Pain And Illnesses[email protected] 
  
What's New
  
  Messages  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  General  
  Games  
  Church Services  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Health Center  
  
  Arthritis  
  
  Back&neck Pain  
  
  Cancer  
  
  Caregiving  
  
  Chronic Ilnness  
  
  Diabetes  
  
  Depression&anxie  
  
  Fibromyalgia  
  
  Health Tips  
  
  Lupus/Autoimmune  
  
  Medication  
  
  Misc. Medical  
  
  MS  
  
  Neurological  
  
  Pain Information  
  
  Rare Diseases  
  
  RSD/CRPS  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Help Center  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Drug Assist Programs  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Dept. Of Aging&Adult Services  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Backgrounds 4 Use  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Pictures  
  Links  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  
  
  Tools  
 
Cancer : New Drug Promising for Hard-to-Treat Prostate Cancer
Choose another message board
 
     
Reply
 Message 1 of 1 in Discussion 
From: MSN Nicknamepray4acure2  (Original Message)Sent: 7/9/2007 7:41 PM
Reported July 9, 2007

New Drug Promising for Hard-to-Treat Prostate Cancer

(Ivanhoe Newswire) -- There is new hope for patients with prostate cancer that is hard to treat. A new drug may bring relief for men whose tumors continue to grow despite medical or surgical castration.

Two new studies from London reveal the drug called abiraterone reduced levels of prostate specific antigen (PSA) -- a marker for cancer activity. It also shrank tumors in patients whose hormone therapy had stopped working and in those previously treated with chemotherapy.

Male hormones such as testosterone are mainly produced in the testes, but they are also produced in other parts of the body. Because the hormones can stimulate prostate cancer cells to grow, the first treatment option for all men with prostate cancer that has spread is chemical suppressants or surgery to stop the production from the testes. But that does not stop the rest of the body from producing male hormones. Abiraterone inhibits an enzyme called CYP450c17, which is critical to the production of male hormones, not only in the testes but elsewhere in the body.

In both studies, men took 1,000 milligrams of abiraterone a day. The first study treated men who had not had chemotherapy before. Of the 34 men treated so far, 22 have had their PSA levels drop at least 50-percent after two months. Some also had their tumors shrink.

The second study looked at 28 men whose cancer was growing despite chemotherapy treatment. Ten of them had their PSA levels go down more than 50 percent and stay down at least three months without bad reactions to the drug.

The authors say the results are significant overall. A Phase III study of the drug is expected to get underway next year.

This article was reported by Ivanhoe.com, which offers Medical Alerts by e-mail every day of the week. To subscribe, click on: http://www.ivanhoe.com/newsalert/.

SOURCE: ESMO Conference Lugano in Lugano, Switzerland, July 5-8, 2007
[email protected]
Copyright © 2007 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802



First  Previous  No Replies  Next  Last